BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30630889)

  • 1. Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography.
    Alcázar JL; Caparros M; Arraiza M; Mínguez JÁ; Guerriero S; Chiva L; Jurado M
    Int J Gynecol Cancer; 2019 Feb; 29(2):227-233. PubMed ID: 30630889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study).
    Fischerova D; Pinto P; Burgetova A; Masek M; Slama J; Kocian R; Frühauf F; Zikan M; Dusek L; Dundr P; Cibula D
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):248-262. PubMed ID: 33871110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery.
    Sørensen SM; Schnack TH; Høgdall C
    Acta Obstet Gynecol Scand; 2019 Jan; 98(1):34-43. PubMed ID: 30168853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.
    Onda T; Tanaka YO; Kitai S; Manabe T; Ishikawa M; Hasumi Y; Miyamoto K; Ogawa G; Satoh T; Saito T; Kasamatsu T; Nakanishi T;
    Jpn J Clin Oncol; 2021 Feb; 51(2):205-212. PubMed ID: 33556170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
    Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
    Lou FL; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
    De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of pouch of Douglas obliteration using offline analysis of the transvaginal ultrasound 'sliding sign' technique: inter- and intra-observer reproducibility.
    Reid S; Lu C; Casikar I; Mein B; Magotti R; Ludlow J; Benzie R; Condous G
    Hum Reprod; 2013 May; 28(5):1237-46. PubMed ID: 23482338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer.
    Stachs A; Engel K; Stubert J; Reimer T; Gerber B; Dieterich M
    Geburtshilfe Frauenheilkd; 2020 Sep; 80(9):915-923. PubMed ID: 32905205
    [No Abstract]   [Full Text] [Related]  

  • 12. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study.
    Fischerova D; Zikan M; Semeradova I; Slama J; Kocian R; Dundr P; Nemejcova K; Burgetova A; Dusek L; Cibula D
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):263-274. PubMed ID: 27091633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
    Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
    Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
    Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
    Gynecol Oncol; 2010 Mar; 116(3):395-8. PubMed ID: 20042226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of ultrasound in assessing the extension of the disease in patients with suspicion of malignant ovarian tumor: correlation between ultrasound parameters and Fagotti's score.
    Moruzzi MC; Bolomini G; Moro F; Mascilini F; Ficarelli S; Beneduce G; Giudice MT; Pasciuto T; Moroni R; Scambia G; Fagotti A; Testa AC
    Int J Gynecol Cancer; 2021 Feb; 31(2):279-285. PubMed ID: 32900793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation and referral guidelines for management of pelvic/ovarian masses.
    Le T; Giede C; Salem S; Lefebvre G; Rosen B; Bentley J; Kupets R; Power P; Renaud MC; Bryson P; Davis DB; Lau S; Lotocki R; Senikas V; Morin L; Bly S; Butt K; Cargill YM; Denis N; Gagnon R; Hietala-Coyle MA; Lim KI; Ouellet A; Raciot MH;
    J Obstet Gynaecol Can; 2009 Jul; 31(7):668-80. PubMed ID: 19761648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
    Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
    J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.